Galectin Therapeutics INC (GALT) — 8-K Filings

All 8-K filings from Galectin Therapeutics INC. Browse 18 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (18)

Galectin Therapeutics Files 8-K on Financials — Mar 31, 2026 Risk: low
Galectin Therapeutics Inc. filed an 8-K on March 31, 2026, reporting on its results of operations and financial condition for the period ending March 31, 2026.
8-K Filing — Dec 19, 2025
8-K Filing — Dec 8, 2025
8-K Filing — Dec 3, 2025
8-K Filing — Nov 10, 2025
Galectin Therapeutics Files 8-K — Sep 8, 2025 Risk: low
Galectin Therapeutics Inc. filed an 8-K on September 8, 2025, reporting on a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not
Galectin Therapeutics Files 8-K with Material Agreement, Director Changes — Jul 9, 2025 Risk: medium
Galectin Therapeutics Inc. announced on July 8, 2025, the entry into a material definitive agreement and changes in its board of directors and officer compensat
Galectin Therapeutics Files 8-K — Jun 16, 2025 Risk: low
Galectin Therapeutics Inc. filed an 8-K on June 16, 2025, reporting on a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly k
Galectin Therapeutics Files 8-K on Financials — May 15, 2025 Risk: low
Galectin Therapeutics Inc. filed an 8-K on May 15, 2025, reporting on its results of operations and financial condition, as well as filing financial statements
Galectin Therapeutics Files 8-K — May 12, 2025 Risk: low
Galectin Therapeutics Inc. filed an 8-K on May 12, 2025, reporting on various events including Regulation FD Disclosures, Other Events, and Financial Statements
Galectin Therapeutics Files 8-K — Mar 5, 2025 Risk: low
Galectin Therapeutics Inc. filed an 8-K on March 5, 2025, reporting on its current activities. The filing primarily serves as a notification of information and
Galectin Therapeutics Files 8-K — Feb 18, 2025 Risk: low
Galectin Therapeutics Inc. filed an 8-K on February 18, 2025, reporting other events and financial statements. The company, formerly known as PRO PHARMACEUTICAL
Galectin Therapeutics Files 8-K on Shareholder Vote Matters — Jan 28, 2025 Risk: low
Galectin Therapeutics Inc. filed an 8-K on January 28, 2025, reporting a submission of matters to a vote of security holders on January 23, 2025. The company, f
Galectin Therapeutics Files 8-K — Jan 23, 2025 Risk: low
Galectin Therapeutics Inc. filed an 8-K on January 23, 2025, reporting on financial statements and exhibits. The company, formerly known as Pro Pharmaceuticals
Galectin Therapeutics Files 8-K — Jan 13, 2025 Risk: low
Galectin Therapeutics Inc. filed an 8-K on January 13, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly k
Galectin Therapeutics Files 8-K — Dec 20, 2024 Risk: low
Galectin Therapeutics Inc. filed an 8-K on December 20, 2024, reporting other events and financial statements. The company, formerly known as Pro Pharmaceutical
Galectin Therapeutics Files 8-K — Sep 9, 2024 Risk: low
Galectin Therapeutics Inc. filed an 8-K on September 9, 2024, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly
Galectin Therapeutics Announces Leadership Changes — Aug 1, 2024 Risk: medium
Galectin Therapeutics Inc. announced on July 26, 2024, the departure of its Chief Medical Officer, Dr. Richard A. Baker. The company also reported the election

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX